You are here: Industry Insights > Multiple

News List

Obesity May Boost Odds for MS in Kids drugs
July 17, 2019
Obese children may be twice as likely to develop multiple sclerosis, a new study suggests.
Obesity Linked to Increased Risk for Pediatric Multiple Sclerosis drugs
July 16, 2019
Obesity seems to be associated with increased odds of pediatric multiple sclerosis (MS), according to a study published online in JAMA Neurology.
Altaire Pharmaceuticals, Inc. Issues Voluntary Recall of Multiple Ophthalmic Products Sold at Wal Mart drugs
July 15, 2019
Altaire Pharmaceuticals, Inc. Issues Voluntary Recall of Multiple Ophthalmic Products Sold at Wal Mart.
Standing Frame Program Can Up Motor Function in Progressive MS drugs
July 15, 2019
Standing Frame Program Can Up Motor Function in Progressive MS.
FDA approves new treatment for refractory multiple myeloma worldpharmanews
July 05, 2019
FDA approves new treatment for refractory multiple myeloma.
Overall Survival Worse With Multiple Primary Melanomas drugs
July 01, 2019
Overall Survival Worse With Multiple Primary Melanomas.
FDA Approves J&J's DARZALEX in Multiple Myeloma contractpharma
July 01, 2019
Results showed that DARZALEX significantly reduced the risk of disease progression or death by 44 percent.
Recommendations Issued for Imaging Use in Multiple Myeloma drugs
June 19, 2019
Recommendations Issued for Imaging Use in Multiple Myeloma.
Recommendations Developed for Pediatric Multiple Sclerosis Trials drugs
June 03, 2019
Recommendations Developed for Pediatric Multiple Sclerosis Trials.
Celgene Submits Application to FDA for Ozanimod for the Treatment of Relapsing Forms of Multiple Sclerosis drugs
April 11, 2019
Celgene Submits Application to FDA for Ozanimod for the Treatment of Relapsing Forms of Multiple Sclerosis.

Previous page 1 2 3 Next page